These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29737248)

  • 1. Targeted Therapies for Autosomal Dominant Polycystic Kidney Disease.
    Stayner C; Brooke DG; Bates M; Eccles MR
    Curr Med Chem; 2019; 26(17):3081-3102. PubMed ID: 29737248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers as first-line treatment in autosomal dominant polycystic kidney disease.
    Clark LA; Whitmire S; Patton S; Clark C; Blanchette CM; Howden R
    J Med Econ; 2017 Jul; 20(7):715-722. PubMed ID: 28332417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination drug versus monotherapy for the treatment of autosomal dominant polycystic kidney disease.
    Rysz J; Gluba-Brzózka A; Franczyk B; Banach M; Bartnicki P
    Expert Opin Pharmacother; 2016 Oct; 17(15):2049-56. PubMed ID: 27650472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal care of autosomal dominant polycystic kidney disease patients.
    Schrier RW
    Nephrology (Carlton); 2006 Apr; 11(2):124-30. PubMed ID: 16669974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive treatments in adult autosomal dominant polycystic kidney disease: network meta-analysis of the randomized controlled trials.
    Xue C; Zhou C; Dai B; Yu S; Xu C; Mao Z; Ye C; Chen D; Zhao X; Wu J; Chen W; Mei C
    Oncotarget; 2015 Dec; 6(40):42515-29. PubMed ID: 26636542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study.
    Torres VE; Meijer E; Bae KT; Chapman AB; Devuyst O; Gansevoort RT; Grantham JJ; Higashihara E; Perrone RD; Krasa HB; Ouyang JJ; Czerwiec FS
    Am J Kidney Dis; 2011 May; 57(5):692-9. PubMed ID: 21333426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspects.
    Saini AK; Saini R; Singh S
    Mol Med; 2020 Dec; 26(1):128. PubMed ID: 33308138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapeutic approaches to autosomal dominant polycystic kidney disease.
    LaRiviere WB; Irazabal MV; Torres VE
    Transl Res; 2015 Apr; 165(4):488-98. PubMed ID: 25438190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic interventions for autosomal dominant polycystic kidney disease.
    Edelstein CL
    Nephrol News Issues; 2008 Mar; 22(3):25-6. PubMed ID: 18372677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in management of autosomal-dominant polycystic kidney disease.
    Potts JW; Mousa SA
    Am J Health Syst Pharm; 2017 Dec; 74(23):1959-1968. PubMed ID: 29167138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal Dominant Polycystic Kidney Disease: Is There a Role for Autophagy?
    Ponticelli C; Moroni G; Reggiani F
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective glycolysis and the use of 2-deoxy-D-glucose in polycystic kidney disease: from animal models to humans.
    Magistroni R; Boletta A
    J Nephrol; 2017 Aug; 30(4):511-519. PubMed ID: 28390001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
    Brosnahan GM; Abebe KZ; Moore CG; Bae KT; Braun WE; Chapman AB; Flessner MF; Harris PC; Hogan MC; Perrone RD; Rahbari-Oskoui FF; Steinman TI; Torres VE; The Halt Pkd Investigators
    Curr Hypertens Rev; 2018; 14(1):39-47. PubMed ID: 29564978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prioritization of novel ADPKD drug candidates from disease-stage specific gene expression profiles.
    Malas TB; Leonhard WN; Bange H; Granchi Z; Hettne KM; Van Westen GJP; Price LS; 't Hoen PAC; Peters DJM
    EBioMedicine; 2020 Jan; 51():102585. PubMed ID: 31879244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE inhibitors, left ventricular mass and renal cyst growth in ADPKD.
    Schrier RW
    Pharmacol Res; 2016 Dec; 114():166-168. PubMed ID: 27794499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of statin and angiotensin-converting enzyme inhibition on structural and hemodynamic alterations in autosomal dominant polycystic kidney disease model.
    Zafar I; Tao Y; Falk S; McFann K; Schrier RW; Edelstein CL
    Am J Physiol Renal Physiol; 2007 Sep; 293(3):F854-9. PubMed ID: 17581927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathogenesis of autosomal dominant polycystic kidney disease.
    Yoder BK; Mulroy S; Eustace H; Boucher C; Sandford R
    Expert Rev Mol Med; 2006 Jan; 8(2):1-22. PubMed ID: 16515728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension in autosomal dominant polycystic kidney disease.
    Chapman AB; Stepniakowski K; Rahbari-Oskoui F
    Adv Chronic Kidney Dis; 2010 Mar; 17(2):153-63. PubMed ID: 20219618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.
    Torres VE; Abebe KZ; Schrier RW; Perrone RD; Chapman AB; Yu AS; Braun WE; Steinman TI; Brosnahan G; Hogan MC; Rahbari FF; Grantham JJ; Bae KT; Moore CG; Flessner MF
    Kidney Int; 2017 Feb; 91(2):493-500. PubMed ID: 27993381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
    Boucher C; Sandford R
    Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.